LFG
SPPI

Larson Financial Group’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Larson Financial Group’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,050
Closed -$4K – 865
2020
Q2 		$4K Hold
1,050
– – ﹤0.01% 515
2020
Q1 		$2K Hold
1,050
– – ﹤0.01% 451
2019
Q4 		$4K Hold
1,050
– – ﹤0.01% 407
2019
Q3 		$9K Buy
+1,050
New +$8.49K 0.01% 323

Other funds holding SPPI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Larson Financial Group's SPPI Position: Q3 2020 in Review

Larson Financial Group sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2020, closing a stake of 1,050 shares — an estimated $4K sold.

Larson Financial Group first reported a position in SPPI in Q3 2019 and held it in 4 quarters. The position peaked at $9K in Q3 2019. 159 funds tracked by Wall St. Rank hold SPPI as of Q3 2020.

  • Larson Financial Group reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2020 after selling out during the quarter.
  • Larson Financial Group sold 1,050 Spectrum Pharmaceuticals Inc shares in Q3 2020, an estimated $4K.
  • Larson Financial Group first reported a position in Spectrum Pharmaceuticals Inc in Q3 2019 and held it in 4 quarters.
  • Larson Financial Group's Spectrum Pharmaceuticals Inc position peaked at $9K in Q3 2019.
  • 159 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2020.

Based on Larson Financial Group's 13F filing for Q3 2020, filed 8 Oct 2020.